Filter by patients with: All

What is Lamivudine (3TC)?

Category: Prescription Drugs

Most popular types: Epivir 3TC Epivir HBV

false

See also: Abacavir-dolutegravir-lamivudine (ABC/DTG/3TC) Abacavir-lamivudine-zidovudine (ABC/3TC/ZDV) Acriptega Triumeq

Lamivudine is a nucleoside reverse transcriptase inhibitor used in the treatment of HIV infection when antiretroviral therapy is warranted; should always be used as part of a multidrug regimen (at least three antiretroviral agents).

See patients taking Lamivudine (3TC)

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Human immunodeficiency virus (HIV) 71 22
Hepatitis B 4 4
Support immune health 2 1
Increase effect of another treatment 1 0
Pain in arm(s) 1 0
  • Major
  • Moderate
  • Slight
  • None
  • Can't tell
See all 142 patients that have taken Lamivudine (3TC)

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 1
Moderate 3
Mild 5
None 18

Commonly reported side effects and conditions associated with Lamivudine (3TC)

Side effect Patients Percentage
Diarrhea 1
Insomnia 1
Nausea 1

Why patients stopped taking Lamivudine (3TC)

Multiple reasons could be selected

Reason Patients Percentage
Doctor's advice 15
Other 5
Side effects too severe 5
Did not seem to work 4
Change in health plan coverage 1
See all 27 patients who've stopped taking Lamivudine (3TC)

Duration

Stopped taking Lamivudine (3TC)

Duration Patients Percentage
6 months - 1 year 2
1 - 2 years 5
2 - 5 years 12
5 - 10 years 6
10 years or more 3
Adherence
Adherence Evaluations Percentage
Always 22
Usually 2
Sometimes 0
Never taken as prescribed 3
Burden
Burden Evaluations Percentage
Very hard to take 1
Somewhat hard to take 2
A little hard to take 3
Not at all hard to take 21
Cost per month
Cost per month Evaluations Percentage
$200+ 1
$100-199 1
$50-99 5
$25-49 1
< $25 9
Not specified 10

What people switch to and from

Patients stopped taking Lamivudine (3TC) and switched to:

Treatment Patients Percentage
Efavirenz-lamivudine-tenofovir disoproxil (EFV/3TC/TDF) 2
Cobicistat-elvitegravir-emtricitabine-tenofovir disoproxil (Stribild) 1
Peginterferon alfa 2a (Pegasys) 1
Triumeq 1
Last updated:

4 patient evaluations for Lamivudine (3TC)

Sort by: Most recent

May 10, 2015 (Started Jan 05, 2011)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 150 mg Daily
Cost: < $25 monthly

Sep 19, 2012 (Started Jan 05, 2011)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 150 mg Daily
Cost: < $25 monthly
  • 0 helpful marks

Sep 10, 2012 (Started Jun 15, 1996)

  • Effectiveness
    Major (for human immunodeficiency virus (HIV))
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 300 mg Daily
Cost: < $25 monthly
  • 0 helpful marks

Jan 4, 2010 (Started Jan 04, 2010)

  • Effectiveness
    None (for human immunodeficiency virus (HIV))
  • Side effects
    Mild
  • Adherence
    Never taken as prescribed
  • Burden
    Not at all hard to take
Dosage: 5 mg Daily
Cost: $100-199 monthly
  • 0 helpful marks
Last updated:
Showing 3 of 4 patient evaluations for Lamivudine (3TC)